Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
7,634,000
|
7,387,000
|
7,497,000
|
7,534,000
| Cost of Revenue | 3,969,000 | 3,991,000 | 3,935,000 | 3,870,000 | |
Gross Profit
|
3,665,000
|
3,396,000
|
3,562,000
|
3,664,000
| |
|
Operating Expenses |
|
Research Development | 430,000 | 418,000 | 397,000 | 408,000 |
|
Selling General and Administrative | 1,589,000 | 1,535,000 | 1,487,000 | 1,528,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,646,000
|
1,443,000
|
1,678,000
|
1,728,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 10,000 | 10,000 | 10,000 | 10,000 |
|
Earnings Before Interest And Taxes | 1,656,000 | 1,453,000 | 1,688,000 | 1,738,000 |
|
Interest Expense | 39,000 | 44,000 | 44,000 | 43,000 |
|
Income Before Tax | 1,617,000 | 1,409,000 | 1,644,000 | 1,695,000 |
|
Income Tax Expense | 470,000 | 405,000 | 464,000 | 509,000 |
|
Minority Interest | (18,000) | (13,000) | (19,000) | (19,000) |
|
|
|
Net Income From Continuing Ops | 1,129,000 | 991,000 | 1,161,000 | 1,167,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,129,000
|
991,000
|
1,161,000
|
1,167,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,129,000
|
991,000
|
1,161,000
|
1,167,000
|
|